Radiation therapy of astrocytomas grades I–IV
✍ Scribed by Charles M. Olmsted; Henry Plenk
- Publisher
- Elsevier Science
- Year
- 1978
- Tongue
- English
- Weight
- 157 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: High grade astrocytomas account for approximately 40% of all primary brain tumors. the median survival is approximately 8-10 months for patients with glioblastoma multiforme and 36 months for patients with anaplastic astrocytoma. the results of systemic chemotherapy in the treatment
Of 77 patients with supratentorial Grades I and I1 astrocytoma diagnosed from
## BACKGROUND. Stereotactic radiotherapy (SRT) is fractionated radiotherapy delivered under stereotactic guidance to produce highly focal and precise therapy. We studied the incidence of imaging changes that can mimic tumor progression after completion of SRT for childhood low grade astrocytoma. #
A pilot study was performed combining cis-diamminedichloroplatinum (CDDP) and radiation therapy to treat patients with high-grade astrocytomas. CDDP at a dose of 40 mg/m2/week intravenously was given during the course of cranial irradiation. Following irradiation, CDDP was given every three weeks on